Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Plains Exploration & Production Company (NYSE:PXP): Insiders Are Dumping, Should You?

Is Plains Exploration & Production Company (NYSE:PXP) a marvelous investment today? The best stock pickers are buying. The number of bullish hedge fund bets went up by 6 lately.

In today’s marketplace, there are many methods market participants can use to monitor stocks. Two of the most under-the-radar are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top fund managers can outclass the S&P 500 by a solid margin (see just how much).

PAULSON & COEqually as integral, optimistic insider trading activity is another way to parse down the marketplace. Just as you’d expect, there are many stimuli for an insider to downsize shares of his or her company, but only one, very obvious reason why they would initiate a purchase. Several academic studies have demonstrated the impressive potential of this method if shareholders understand what to do (learn more here).

With these “truths” under our belt, we’re going to take a gander at the recent action encompassing Plains Exploration & Production Company (NYSE:PXP).

How have hedgies been trading Plains Exploration & Production Company (NYSE:PXP)?

In preparation for this year, a total of 37 of the hedge funds we track held long positions in this stock, a change of 19% from the previous quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists a few noteworthy hedge fund managers who were upping their stakes substantially.

According to our comprehensive database, Paulson & Co, managed by John Paulson, holds the most valuable position in Plains Exploration & Production Company (NYSE:PXP). Paulson & Co has a $601 million position in the stock, comprising 3.7% of its 13F portfolio. On Paulson & Co’s heels is Robert Emil Zoellner of Alpine Associates, with a $178 million position; 3.7% of its 13F portfolio is allocated to the stock. Some other hedgies that are bullish include Sean Cullinan’s Point State Capital, and D. E. Shaw’s D E Shaw.

As industrywide interest jumped, key hedge funds have been driving this bullishness. Paulson & Co, managed by John Paulson, created the most outsized position in Plains Exploration & Production Company (NYSE:PXP). Paulson & Co had 601 million invested in the company at the end of the quarter. Robert Emil Zoellner’s Alpine Associates also initiated a $178 million position during the quarter. The other funds with new positions in the stock are Matthew Halbower’s Pentwater Capital Management, James Dinan’s York Capital Management, and George Soros’s Soros Fund Management.

How are insiders trading Plains Exploration & Production Company (NYSE:PXP)?

Insider buying is best served when the primary stock in question has experienced transactions within the past 180 days. Over the last six-month time frame, Plains Exploration & Production Company (NYSE:PXP) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

With the returns exhibited by our studies, retail investors must always monitor hedge fund and insider trading sentiment, and Plains Exploration & Production Company (NYSE:PXP) shareholders fit into this picture quite nicely.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!